Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA PROCTER & GAMBLE HEALTH CIPLA/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 32.3 34.4 93.8% View Chart
P/BV x 5.2 10.5 49.3% View Chart
Dividend Yield % 0.6 2.0 28.1%  

Financials

 CIPLA   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    CIPLA
Mar-23
PROCTER & GAMBLE HEALTH
Jun-23
CIPLA/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs1,1855,366 22.1%   
Low Rs8523,883 21.9%   
Sales per share (Unadj.) Rs281.9740.7 38.1%  
Earnings per share (Unadj.) Rs35.1138.2 25.4%  
Cash flow per share (Unadj.) Rs49.7155.2 32.0%  
Dividends per share (Unadj.) Rs8.5095.00 8.9%  
Avg Dividend yield %0.82.1 40.6%  
Book value per share (Unadj.) Rs289.2447.6 64.6%  
Shares outstanding (eoy) m807.1516.60 4,862.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.66.2 57.9%   
Avg P/E ratio x29.033.5 86.7%  
P/CF ratio (eoy) x20.529.8 68.8%  
Price / Book Value ratio x3.510.3 34.1%  
Dividend payout %24.268.7 35.2%   
Avg Mkt Cap Rs m822,16476,761 1,071.1%   
No. of employees `000NANA-   
Total wages/salary Rs m38,3012,062 1,857.7%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m227,53112,296 1,850.4%  
Other income Rs m5,121184 2,784.8%   
Total revenues Rs m232,65312,480 1,864.2%   
Gross profit Rs m48,0793,247 1,480.8%  
Depreciation Rs m11,721281 4,171.2%   
Interest Rs m1,0958 14,226.0%   
Profit before tax Rs m40,3843,142 1,285.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,029847 1,419.6%   
Profit after tax Rs m28,3552,295 1,235.7%  
Gross profit margin %21.126.4 80.0%  
Effective tax rate %29.827.0 110.5%   
Net profit margin %12.518.7 66.8%  
BALANCE SHEET DATA
Current assets Rs m168,05111,713 1,434.8%   
Current liabilities Rs m50,3336,791 741.2%   
Net working cap to sales %51.740.0 129.3%  
Current ratio x3.31.7 193.6%  
Inventory Days Days73263 27.9%  
Debtors Days Days7343 1.9%  
Net fixed assets Rs m117,31810,617 1,105.0%   
Share capital Rs m1,614166 972.5%   
"Free" reserves Rs m231,8457,265 3,191.5%   
Net worth Rs m233,4607,431 3,141.9%   
Long term debt Rs m00-   
Total assets Rs m290,06722,330 1,299.0%  
Interest coverage x37.9409.1 9.3%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 142.4%   
Return on assets %10.210.3 98.5%  
Return on equity %12.130.9 39.3%  
Return on capital %17.842.4 41.9%  
Exports to sales %22.60-   
Imports to sales %8.913.1 68.0%   
Exports (fob) Rs m51,516NA-   
Imports (cif) Rs m20,2021,605 1,258.4%   
Fx inflow Rs m64,2821,465 4,387.2%   
Fx outflow Rs m20,2021,605 1,258.4%   
Net fx Rs m44,080-140 -31,440.7%   
CASH FLOW
From Operations Rs m32,3772,360 1,371.9%  
From Investments Rs m-23,885-215 11,109.3%  
From Financial Activity Rs m-9,583-985 973.2%  
Net Cashflow Rs m-9681,160 -83.4%  

Share Holding

Indian Promoters % 13.4 0.0 -  
Foreign collaborators % 20.0 51.8 38.7%  
Indian inst/Mut Fund % 50.0 20.3 246.7%  
FIIs % 25.7 7.6 338.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.5 48.2 138.1%  
Shareholders   425,731 56,730 750.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Cipla vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs Procter & Gamble Health Share Price Performance

Period Cipla Procter & Gamble Health S&P BSE HEALTHCARE
1-Day 2.14% -0.69% 1.18%
1-Month 1.44% -7.59% -0.75%
1-Year 68.35% -3.15% 61.82%
3-Year CAGR 22.61% -9.16% 18.16%
5-Year CAGR 23.28% 5.72% 19.79%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.5% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 8.5 per share. This amounted to a Dividend Payout ratio of 24.2%.

Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.

You may visit here to review the dividend history of Cipla, and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.